The Constantia Tobepal company has been recognized by Almirall with the delivery of the 24th sales unit of the new COPD inhaler, which was launched on the market in September 2012. Almirall commented that Constantia Tobepal is a vital partner for the success of the launch of this new and innovative pharmaceutical product. Constantia Tobepal has collaborated with Almirall from product development to final result in terms of packaging design and technical and machinability tests. The inhaler is packaged in a PET / Alu / PE structure package.
